Publications by authors named "Marie Marcq"

Claim this Profile
A
Absolute Quantification of Nucleotide Variants in Cell-Free DNA via Quantitative NGS: Clinical Application in Non-Small Cell Lung Cancer Patients.
Guillaume Herbreteau, Marie Marcq, Chloé Sauzay, Maxime Carpentier, Elise Pierre-Noël

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comparative Multicenter Cohort Study Evaluating the Long-Term Influence of the Strict Lockdown during the First COVID-19 Wave on Lung Cancer Patients (ARTEMISIA Trial).
Olivier Molinier, Camille Guguen, Marie Marcq, Anne-Laure Chene, Philippe Masson

Cancers (Basel)· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Overall Survival of Patients With Advanced Non-Small-Cell Lung Cancers With ≥50% PD-L1 Expression Treated With First-Line Pembrolizumab Monotherapy in a Real-World Setting (ESCKEYP GFPC Study).
Chantal Decroisette, Laurent Greillier, Hubert Curcio, Maurice Pérol, Charles Ricordel, Marie Marcq

J Immunother· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study).
Renaud Descourt, Laurent Greillier, Maurice Perol, Charles Ricordel, Jean-Bernard Auliac, Marie Marcq

Cancer Immunol Immunother· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression: The MELROSE Trial.
Jaafar Bennouna, Nicolas Girard, Clarisse Audigier-Valette, Aurélie le Thuaut, Radj Gervais, Marie Marcq

Clin Lung Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer and Preexisting Autoimmune Disease: A Nationwide, Multicenter Cohort Study.
Alice Tison, Gilles Quéré, Laurent Misery, Elisa Funck-Brentano, François-Xavier Danlos, Marie Marcq

Arthritis Rheumatol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01).
Alain Vergnenègre, Victor Basse, Gwenaelle Le Garff, Olivier Bylicki, Catherine Dubos-Arvis, Marie Marcq

Cancer Manag Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer with Leptomeningeal Metastases Pretreated with EGFR-Tyrosine Kinase Inhibitors.
Karima Saboundji, Jean-Bernard Auliac, Maurice Pérol, Géraldine François, Henri Janicot, Marie Marcq

Target Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study.
Romain Corre, Laurent Greillier, Hervé Le Caër, Clarisse Audigier-Valette, Nathalie Baize, Marie Marcq

J Clin Oncol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of EGFR mutations in the plasma of patients with lung adenocarcinoma for real-time monitoring of therapeutic response to tyrosine kinase inhibitors?
Marie Marcq, Audrey Vallée, Acya Bizieux, Marc G Denis

J Thorac Oncol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma is a better source of tumor-derived circulating cell-free DNA than serum for the detection of EGFR alterations in lung tumor patients.
Audrey Vallée, Marie Marcq, Acya Bizieux, Claude El Kouri, Hervé Lacroix

Lung Cancer· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells.
Frédéric Ebstein, Carole Sapede, Pierre-Joseph Royer, Marie Marcq, Catherine Ligeza-Poisson

Am J Respir Crit Care Med· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis